Stroke and Thromboprophylaxis in the Era of COVID-19

J Stroke Cerebrovasc Dis. 2021 Jan;30(1):105392. doi: 10.1016/j.jstrokecerebrovasdis.2020.105392. Epub 2020 Oct 9.
No abstract available

Keywords: COVID-19; DVT; Endovascular; PE; SARS CoV-2; Stroke; Thromboprophylaxis; VTE.

Publication types

  • Review

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • COVID-19 / complications
  • COVID-19 / diagnosis
  • COVID-19 Drug Treatment*
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Intermittent Pneumatic Compression Devices* / adverse effects
  • Risk Assessment
  • Risk Factors
  • Stroke / diagnosis
  • Stroke / epidemiology
  • Stroke / prevention & control*
  • Thromboembolism / diagnosis
  • Thromboembolism / etiology
  • Thromboembolism / prevention & control*
  • Thrombosis / diagnosis
  • Thrombosis / etiology
  • Thrombosis / prevention & control*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Fibrinolytic Agents